HBK Sorce Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.07M | Sell |
157,717
-1,436
| -0.9% | -$37.6K | 0.08% | 92 |
|
|
2026
Q1 | $4.09M | Buy |
159,153
+7,494
| +5% | +$200K | 0.08% | 89 |
|
|
2025
Q4 | $4.13M | Sell |
151,659
-9,192
| -6% | -$232K | 0.09% | 90 |
|
|
2025
Q3 | $3.92M | Buy |
160,851
+8,788
| +6% | +$217K | 0.1% | 87 |
|
|
2025
Q2 | $3.69M | Buy |
152,063
+7,999
| +6% | +$187K | 0.1% | 90 |
|
|
2025
Q1 | $3.65M | Buy |
144,064
+30,931
| +27% | +$809K | 0.11% | 87 |
|
|
2024
Q4 | $3M | Sell |
113,133
-26,759
| -19% | -$726K | 0.09% | 101 |
|
|
2024
Q3 | $4.05M | Buy |
139,892
+4,334
| +3% | +$126K | 0.12% | 78 |
|
|
2024
Q2 | $3.79M | Buy |
135,558
+9,018
| +7% | +$248K | 0.13% | 74 |
|
|
2024
Q1 | $3.51M | Buy |
126,540
+6,367
| +5% | +$177K | 0.12% | 87 |
|
|
2023
Q4 | $3.46M | Sell |
120,173
-9,588
| -7% | -$290K | 0.13% | 81 |
|
|
2023
Q3 | $4.3M | Buy |
129,761
+2,870
| +2% | +$101K | 0.19% | 65 |
|
|
2023
Q2 | $4.65M | Buy |
126,891
+16,062
| +14% | +$625K | 0.2% | 67 |
|
|
2023
Q1 | $4.52M | Sell |
110,829
-160,513
| -59% | -$6.93M | 0.21% | 63 |
|
|
2022
Q4 | $13.9M | Buy |
271,342
+151,706
| +127% | +$7.27M | 0.37% | 41 |
|
|
2022
Q3 | $5.24M | Buy |
119,636
+40,713
| +52% | +$1.98M | 0.35% | 47 |
|
|
2022
Q2 | $4.14M | Sell |
78,923
-46,468
| -37% | -$2.37M | 0.31% | 45 |
|
|
2022
Q1 | $6.49M | Sell |
125,391
-12,332
| -9% | -$640K | 0.36% | 43 |
|
|
2021
Q4 | $8.13M | Sell |
137,723
-861
| -0.6% | -$42.7K | 0.41% | 38 |
|
|
2021
Q3 | $5.96M | Sell |
138,584
-16,517
| -11% | -$732K | 0.33% | 41 |
|
|
2021
Q2 | $6.07M | Buy |
155,101
+24,596
| +19% | +$956K | 0.34% | 42 |
|
|
2021
Q1 | $4.73M | Buy |
130,505
+2,138
| +2% | +$75.9K | 0.28% | 52 |
|
|
2020
Q4 | $4.72M | Buy |
128,367
+4,209
| +3% | +$154K | 0.29% | 47 |
|
|
2020
Q3 | $4.32M | Buy |
124,158
+4,016
| +3% | +$141K | 0.31% | 45 |
|
|
2020
Q2 | $3.73M | Buy |
120,142
+6,757
| +6% | +$230K | 0.28% | 55 |
|
|
2020
Q1 | $3.51M | Sell |
113,385
-5,929
| -5% | -$202K | 0.34% | 41 |
|
|
2019
Q4 | $4.43M | Buy |
119,314
+9,566
| +9% | +$341K | 0.39% | 46 |
|
|
2019
Q3 | $3.74M | Buy |
109,748
+2,637
| +2% | +$95.9K | 0.36% | 53 |
|
|
2019
Q2 | $4.4M | Buy |
107,111
+5,027
| +5% | +$200K | 0.42% | 41 |
|
|
2019
Q1 | $4.11M | Buy |
102,084
+745
| +0.7% | +$29.8K | 0.41% | 46 |
|
|
2018
Q4 | $4.2M | Buy |
101,339
+1,719
| +2% | +$71.4K | 0.48% | 41 |
|
|
2018
Q3 | $4.17M | Sell |
99,620
-1,503
| -1% | -$57.9K | 0.47% | 37 |
|
|
2018
Q2 | $3.48M | Sell |
101,123
-4,238
| -4% | -$145K | 0.4% | 50 |
|
|
2018
Q1 | $3.55M | Buy |
105,361
+8,015
| +8% | +$276K | 0.45% | 41 |
|
|
2017
Q4 | $3.35M | Buy |
97,346
+23,094
| +31% | +$787K | 0.39% | 45 |
|
|
2017
Q3 | $2.52M | Sell |
74,252
-8,890
| -11% | -$286K | 0.38% | 42 |
|
|
2017
Q2 | $2.65M | Buy |
+83,142
| New | +$2.62M | 0.42% | 38 |
|
|
2017
Q1 | – | Sell |
-82,415
| Closed | -$2.6M | – | 385 |
|
|
2016
Q4 | $2.54M | Buy |
82,415
+287
| +0.3% | +$8.76K | 0.46% | 38 |
|
|
2016
Q3 | $2.64M | Buy |
82,128
+3,650
| +5% | +$122K | 0.52% | 30 |
|
|
2016
Q2 | $2.62M | Buy |
78,478
+7,325
| +10% | +$234K | 0.56% | 27 |
|
|
2016
Q1 | $2M | Buy |
71,153
+44,150
| +164% | +$1.26M | 0.47% | 31 |
|
|
2015
Q4 | $827K | Buy |
27,003
+878
| +3% | +$27.6K | 0.22% | 72 |
|
|
2015
Q3 | $779K | Buy |
26,125
+1,272
| +5% | +$40.8K | 0.25% | 56 |
|
|
2015
Q2 | $791K | Sell |
24,853
-693
| -3% | -$22.6K | 0.27% | 60 |
|
|
2015
Q1 | $843K | Sell |
25,546
-983
| -4% | -$31.3K | 0.29% | 57 |
|
|
2014
Q4 | $783K | Buy |
26,529
+3,958
| +18% | +$113K | 0.27% | 64 |
|
|
2014
Q3 | $633K | Sell |
22,571
-2,716
| -11% | -$76.2K | 0.23% | 64 |
|
|
2014
Q2 | $712K | Buy |
25,287
+1,013
| +4% | +$28.9K | 0.25% | 60 |
|
|
2014
Q1 | $740K | Sell |
24,274
-426
| -2% | -$12.7K | 0.27% | 57 |
|
|
2013
Q4 | $718K | Buy |
24,700
+1,999
| +9% | +$58.2K | 0.26% | 56 |
|
|
2013
Q3 | $619K | Sell |
22,701
-20,157
| -47% | -$548K | 0.26% | 59 |
|
|
2013
Q2 | $1.14M | Buy |
+42,858
| New | +$1.18M | 0.25% | 63 |
|
Other funds holding PFE
HBK Sorce Advisory's PFE Position: Q2 2026 in Review
HBK Sorce Advisory reduced its Pfizer (PFE) stake by 0.9% in Q2 2026, selling an estimated $37.6K and leaving 157,717 shares worth $4.07M. The position accounts for 0.08% of the portfolio, ranked #92.
HBK Sorce Advisory first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.9M in Q4 2022. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- HBK Sorce Advisory held 157,717 shares of Pfizer worth $4.07M as of Q2 2026.
- HBK Sorce Advisory sold 1,436 Pfizer shares in Q2 2026, an estimated $37.6K.
- Pfizer made up 0.08% of HBK Sorce Advisory's portfolio in Q2 2026, its #92 holding.
- HBK Sorce Advisory first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- HBK Sorce Advisory's Pfizer position peaked at $13.9M in Q4 2022.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.